Extract notice to the Minister

Brukinsa (LLC et Waldenström)

Common name / Subject : zanubrutinib
Name of the manufacturer : BeiGene
Form : Co.
Dosage : 160 mg

Indication : Leucémie lymphoïde chronique, Macroglobulinémie de Waldenström

INESSS' Recommendation
Inscription - Sous conditions

Minister's decisions
À venir

Evaluation published on June 04, 2025

Download Advice to minister about Brukinsa (LLC et Waldenström)

Extrait d'avis au ministre sur Brukinsa 330 KiO

Subscribe to our newsletter now

Subscription